A	O
regulatory	B-DNA
element	I-DNA
in	O
the	O
human	B-DNA
interleukin	I-DNA
2	I-DNA
gene	I-DNA
promoter	I-DNA
is	O
a	O
binding	B-DNA
site	I-DNA
for	O
the	O
zinc	B-protein
finger	I-protein
proteins	I-protein
Sp1	B-protein
and	O
EGR-1	B-protein
.	O

Activation	O
of	O
the	O
interleukin	B-DNA
2	I-DNA
(	I-DNA
IL-2	I-DNA
)	I-DNA
gene	I-DNA
after	O
antigen	O
recognition	O
is	O
a	O
critical	O
event	O
for	O
T	O
cell	O
proliferation	O
and	O
effector	O
function	O
.	O

Prior	O
studies	O
have	O
identified	O
several	O
transcription	B-protein
factors	I-protein
that	O
contribute	O
to	O
the	O
activity	O
of	O
the	O
IL-2	B-DNA
promoter	I-DNA
in	O
stimulated	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
.	O

Here	O
we	O
describe	O
a	O
novel	O
regulatory	B-DNA
element	I-DNA
within	O
the	O
IL-2	B-DNA
promoter	I-DNA
located	O
immediately	O
upstream	O
of	O
the	O
nuclear	B-DNA
factor	I-DNA
of	I-DNA
activated	I-DNA
T	I-DNA
cell	I-DNA
(	I-DNA
NFAT	I-DNA
)	I-DNA
domain	I-DNA
.	O

This	O
region	O
(	O
termed	O
the	O
zinc	B-DNA
finger	I-DNA
protein	I-DNA
binding	I-DNA
region	I-DNA
(	O
ZIP	B-DNA
)	O
)	O
serves	O
as	O
binding	O
site	O
for	O
two	O
differently	O
regulated	O
zinc	B-protein
finger	I-protein
proteins	I-protein
:	O
the	O
constitutively	B-protein
expressed	I-protein
transcription	I-protein
factor	I-protein
Sp1	B-protein
and	O
the	O
inducible	B-protein
early	I-protein
growth	I-protein
response	I-protein
protein	I-protein
EGR-1	B-protein
.	O

In	O
unstimulated	B-cell_type
cells	I-cell_type
which	O
do	O
not	O
secrete	O
IL-2	B-protein
,	O
only	O
Sp1	B-protein
binds	O
to	O
this	O
region	O
,	O
while	O
in	O
stimulated	B-cell_line
IL-2	I-cell_line
secreting	I-cell_line
cells	I-cell_line
the	O
inducible	B-protein
EGR-1	I-protein
protein	I-protein
recognizes	O
this	O
element	O
.	O

In	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
,	O
the	O
ZIP	B-DNA
site	I-DNA
serves	O
as	O
an	O
activator	O
for	O
IL-2	B-protein
gene	O
expression	O
,	O
and	O
a	O
combination	O
of	O
ZIP	B-DNA
and	O
NFAT	B-DNA
binding	I-DNA
sites	I-DNA
is	O
required	O
for	O
maximal	O
IL-2	B-DNA
promoter	I-DNA
activity	O
.	O

These	O
results	O
suggest	O
a	O
critical	O
role	O
of	O
the	O
ZIP	B-DNA
site	I-DNA
for	O
IL-2	B-DNA
promoter	I-DNA
activity	O
.	O

THE	NULL
JoUrNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Â©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

38	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
22	NULL
,	NULL
pp	NULL
.	NULL

22500-22506	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
A	NULL
Regulatory	NULL
Element	NULL
in	NULL
the	NULL
Human	NULL
Interleukin	NULL
2	NULL
Gene	NULL
Promoter	NULL
Is	NULL
a	NULL
Binding	NULL
Site	NULL
for	NULL
the	NULL
Zinc	NULL
Finger	NULL
Proteins	NULL
Spl	NULL
and	NULL
EGR-1*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
April	NULL
27	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
July	NULL
17	NULL
,	NULL
1995	NULL
)	NULL
Christine	NULL
Skerka	NULL
,	NULL
Eva	NULL
L.	NULL
Decker	NULL
,	NULL
and	NULL
Peter	NULL
F.	NULL
Zipfel	NULL
#	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Bernhard	NULL
Nocht	NULL
Institute	NULL
for	NULL
Tropical	NULL
Medicine	NULL
,	NULL
Bernhard-Nocht-Strasse	NULL
74	NULL
,	NULL
D-20359	NULL
Hamburg	NULL
,	NULL
Germany	NULL
Activation	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
gene	NULL
after	NULL
antigen	NULL
recognition	NULL
is	NULL
a	NULL
critical	NULL
event	NULL
for	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
effector	NULL
function	NULL
.	NULL

Prior	NULL
studies	NULL
have	NULL
identified	NULL
several	NULL
transcription	NULL
factors	NULL
that	NULL
contribute	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Here	NULL
we	NULL
describe	NULL
a	NULL
novel	NULL
regulatory	NULL
element	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
located	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cell	NULL
(	NULL
NFAT	NULL
)	NULL
domain	NULL
.	NULL

This	NULL
region	NULL
(	NULL
termed	NULL
the	NULL
zinc	NULL
finger	NULL
protein	NULL
binding	NULL
region	NULL
(	NULL
ZIP	NULL
)	NULL
)	NULL
serves	NULL
as	NULL
binding	NULL
site	NULL
for	NULL
two	NULL
differently	NULL
regulated	NULL
zinc	NULL
finger	NULL
proteins	NULL
:	NULL
the	NULL
constitutively	NULL
expressed	NULL
transcription	NULL
factor	NULL
Spl	NULL
and	NULL
the	NULL
inducible	NULL
early	NULL
growth	NULL
response	NULL
protein	NULL
EGR-1	NULL
.	NULL

In	NULL
unstimulated	NULL
cells	NULL
which	NULL
do	NULL
not	NULL
secrete	NULL
IL-2	NULL
,	NULL
only	NULL
Sp1	NULL
binds	NULL
to	NULL
this	NULL
region	NULL
,	NULL
while	NULL
in	NULL
stimulated	NULL
IL-2	NULL
secreting	NULL
cells	NULL
the	NULL
inducible	NULL
EGR-1	NULL
protein	NULL
recognizes	NULL
this	NULL
element	NULL
.	NULL

In	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
ZIP	NULL
site	NULL
serves	NULL
as	NULL
an	NULL
activator	NULL
for	NULL
IL-2	NULL
gene	NULL
expression	NULL
,	NULL
and	NULL
a	NULL
combination	NULL
of	NULL
ZIP	NULL
and	NULL
NFAT	NULL
binding	NULL
sites	NULL
is	NULL
required	NULL
for	NULL
maximal	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
a	NULL
critical	NULL
role	NULL
of	NULL
the	NULL
ZIP	NULL
site	NULL
for	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
by	NULL
antigenic	NULL
peptides	NULL
in	NULL
combination	NULL
with	NULL
antigen	NULL
presenting	NULL
cells	NULL
induces	NULL
a	NULL
cascade	NULL
of	NULL
metabolic	NULL
events	NULL
which	NULL
result	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
different	NULL
genes	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
transcripts	NULL
induced	NULL
in	NULL
the	NULL
``	NULL
immediate	NULL
early	NULL
phase	NULL
,	NULL
``	NULL
i.e	NULL
.	NULL

about	NULL
15	NULL
min	NULL
following	NULL
the	NULL
activating	NULL
stimulus	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
are	NULL
a	NULL
large	NULL
number	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

These	NULL
factors	NULL
are	NULL
considered	NULL
to	NULL
regulate	NULL
the	NULL
induction	NULL
of	NULL
genes	NULL
which	NULL
are	NULL
transcribed	NULL
in	NULL
a	NULL
second	NULL
phase	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
``	NULL
early	NULL
phase	NULL
.	NULL
``	NULL

A	NULL
family	NULL
of	NULL
genes	NULL
,	NULL
termed	NULL
``	NULL
early	NULL
growth	NULL
response	NULL
genes	NULL
``	NULL
(	NULL
EGR	NULL
)	NULL
,	NULL
which	NULL
encode	NULL
DNA-binding	NULL
proteins	NULL
with	NULL
almost	NULL
identical	NULL
zinc	NULL
finger	NULL
domains	NULL
is	NULL
induced	NULL
directly	NULL
in	NULL
the	NULL
immediate	NULL
early	NULL
phase	NULL
.	NULL

The	NULL
four	NULL
EGR	NULL
genes	NULL
,	NULL
termed	NULL
EGR-1	NULL
(	NULL
3	NULL
)	NULL
,	NULL
EGR-2	NULL
(	NULL
4	NULL
)	NULL
,	NULL
EGR-3	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
and	NULL
EGR-4/pAT133	NULL
(	NULL
5	NULL
,	NULL
7	NULL
)	NULL
are	NULL
coordinately	NULL
regulated	NULL
.	NULL

No	NULL
transcript	NULL
is	NULL
detected	NULL
in	NULL
quiescent	NULL
,	NULL
nonproliferating	NULL
T	NULL
lymphocytes	NULL
,	NULL
nor	NULL
in	NULL
resting	NULL
,	NULL
serum-deprived	NULL
fibroblasts	NULL
;	NULL
however	NULL
,	NULL
all	NULL
genes	NULL
are	NULL
transiently	NULL
induced	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cells	NULL
upon	NULL
mitogenic	NULL
stimulation	NULL
(	NULL
8-13	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
four	NULL
proteins	NULL
are	NULL
closely	NULL
related	NULL
within	NULL
their	NULL
zinc	NULL
finger	NULL
domains	NULL
,	NULL
their	NULL
flanking	NULL
regions	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
(	NULL
DFG	NULL
)	NULL
Grant	NULL
Zi	NULL
432/2-1	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
}	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
0049-40-3-11-82-472	NULL
;	NULL
Fax	NULL
:	NULL
0049-40-8-11-82-400	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
EGR	NULL
,	NULL
early	NULL
growth	NULL
response	NULL
genes	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
ZIP	NULL
,	NULL
zinc	NULL
finger	NULL
protein	NULL
binding	NULL
region	NULL
;	NULL
AP-1	NULL
,	NULL
activator	NULL
protein	NULL
1	NULL
;	NULL
IL-2	NULL
,	NULL
interleukin	NULL
2	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglutinin	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
.	NULL

are	NULL
much	NULL
less	NULL
conserved	NULL
.	NULL

As	NULL
already	NULL
expected	NULL
from	NULL
the	NULL
high	NULL
amino	NULL
acid	NULL
homology	NULL
of	NULL
their	NULL
zinc	NULL
finger	NULL
domains	NULL
,	NULL
in	NULL
vitro	NULL
experiments	NULL
confirmed	NULL
binding	NULL
of	NULL
all	NULL
four	NULL
proteins	NULL
to	NULL
the	NULL
same	NULL
target	NULL
sequence	NULL
,	NULL
i.e	NULL
.	NULL

GCG	NULL
G/TGG	NULL
GCG	NULL
(	NULL
4-6	NULL
,	NULL
13-18	NULL
)	NULL
.	NULL

Despite	NULL
binding	NULL
to	NULL
the	NULL
identical	NULL
sequence	NULL
,	NULL
the	NULL
amino	NULL
acid	NULL
differences	NULL
in	NULL
the	NULL
flanking	NULL
regions	NULL
suggest	NULL
distinct	NULL
biological	NULL
functions	NULL
of	NULL
the	NULL
four	NULL
proteins	NULL
.	NULL

As	NULL
primary	NULL
response	NULL
factors	NULL
,	NULL
EGR-1	NULL
to	NULL
EGR-4	NULL
are	NULL
candidates	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
distal	NULL
gene	NULL
expression	NULL
.	NULL

Based	NULL
on	NULL
their	NULL
later	NULL
time	NULL
course	NULL
of	NULL
induction	NULL
,	NULL
cytokine	NULL
genes	NULL
are	NULL
likely	NULL
target	NULL
genes	NULL
for	NULL
EGR	NULL
regulation	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

In	NULL
order	NULL
to	NULL
provide	NULL
evidence	NULL
for	NULL
such	NULL
a	NULL
regulation	NULL
,	NULL
we	NULL
searched	NULL
for	NULL
EGR	NULL
binding	NULL
motifs	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
human	NULL
cytokine	NULL
genes	NULL
.	NULL

This	NULL
approach	NULL
resulted	NULL
in	NULL
the	NULL
identification	NULL
of	NULL
putative	NULL
EGR	NULL
binding	NULL
motifs	NULL
within	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
genes	NULL
.	NULL

The	NULL
EGR	NULL
motif	NULL
in	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
promoter	NULL
has	NULL
recently	NULL
been	NULL
characterized	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
EGR-1	NULL
protein	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
and	NULL
IL-2	NULL
secretion	NULL
are	NULL
essential	NULL
steps	NULL
for	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
effector	NULL
functions	NULL
.	NULL

IL-2	NULL
gene	NULL
regulation	NULL
is	NULL
analyzed	NULL
extensively	NULL
,	NULL
and	NULL
several	NULL
regulatory	NULL
elements	NULL
and	NULL
their	NULL
corresponding	NULL
binding	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
both	NULL
the	NULL
human	NULL
and	NULL
the	NULL
mouse	NULL
IL-2	NULL
promoter	NULL
(	NULL
1	NULL
,	NULL
20-24	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
IL-2	NULL
gene	NULL
expression	NULL
has	NULL
been	NULL
demonstrated	NULL
for	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
factor	NULL
assembles	NULL
only	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
25-27	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
binding	NULL
region	NULL
includes	NULL
a	NULL
purine-rich	NULL
stretch	NULL
and	NULL
an	NULL
AP-1	NULL
site	NULL
.	NULL

Binding	NULL
of	NULL
members	NULL
of	NULL
the	NULL
fos	NULL
and	NULL
jun	NULL
gene	NULL
family	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
has	NULL
been	NULL
demonstrated	NULL
(	NULL
28	NULL
)	NULL
,	NULL
and	NULL
two	NULL
factors	NULL
(	NULL
termed	NULL
NFATc	NULL
and	NULL
NFATp	NULL
)	NULL
which	NULL
bind	NULL
to	NULL
the	NULL
purine-rich	NULL
region	NULL
directly	NULL
upstream	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
have	NULL
been	NULL
cloned	NULL
recently	NULL
(	NULL
25	NULL
,	NULL
29	NULL
)	NULL
.	NULL

The	NULL
putative	NULL
EGR	NULL
recognition	NULL
element	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
is	NULL
located	NULL
directly	NULL
upstream	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
.	NULL

We	NULL
asked	NULL
whether	NULL
this	NULL
site	NULL
serves	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
nuclear	NULL
proteins	NULL
and	NULL
whether	NULL
it	NULL
participates	NULL
in	NULL
transcriptional	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
this	NULL
G-rich	NULL
domain	NULL
is	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
two	NULL
zinc	NULL
finger	NULL
proteins	NULL
Spl	NULL
and	NULL
EGR-1	NULL
.	NULL

In	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
this	NULL
EGR-1	NULL
binding	NULL
element	NULL
is	NULL
a	NULL
novel	NULL
and	NULL
important	NULL
regulatory	NULL
element	NULL
for	NULL
IL-2	NULL
gene	NULL
activation	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Insect	NULL
Cell	NULL
Culture-	NULL
Spodoptera	NULL
frugiperda	NULL
cells	NULL
(	NULL
Sf9	NULL
)	NULL
were	NULL
grown	NULL
at	NULL
27	NULL
Â°C	NULL
in	NULL
monolayer	NULL
culture	NULL
,	NULL
in	NULL
Grace	NULL
's	NULL
medium	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
streptomycin	NULL
(	NULL
0.2	NULL
ug/ml	NULL
)	NULL
,	NULL
penicillin	NULL
(	NULL
0.2	NULL
units/ml	NULL
)	NULL
,	NULL
and	NULL
fungizone	NULL
(	NULL
250	NULL
ng/ml	NULL
)	NULL
or	NULL
in	NULL
fetal	NULL
bovine	NULL
serum-free	NULL
Express-medium	NULL
(	NULL
BioWhittaker	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
Recombinant	NULL
Proteins	NULL
in	NULL
the	NULL
Baculovirus	NULL
System	NULL
22500	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Zinc	NULL
Finger	NULL
Binding	NULL
Element	NULL
in	NULL
the	NULL
Human	NULL
IL-2	NULL
Promoter	NULL
A	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Protein	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
between	NULL
posi-	NULL
5+	NULL
tion	NULL
-250	NULL
and	NULL
-303	NULL
.	NULL

A	NULL
,	NULL
nucleotide	NULL
se-	NULL
3+	NULL
quence	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
region	NULL
-250	NULL
to	NULL
-300	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
Binding	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

The	NULL
protein	NULL
.	NULL

binding	NULL
sites	NULL
required	NULL
for	NULL
NFAT	NULL
and	NULL
AP-1	NULL
site	NULL
ZIP	NULL
binding	NULL
are	NULL
boxed	NULL
.	NULL

The	NULL
ZIP	NULL
site	NULL
is	NULL
de	NULL
scribed	NULL
in	NULL
this	NULL
paper	NULL
.	NULL

B	NULL
,	NULL
sequence	NULL
of	NULL
oli-	NULL
gonucleotides	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

ZIP	NULL
represents	NULL
the	NULL
nucleotide	NULL
sequences	NULL
-303	NULL
to	NULL
-280	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
pro	NULL
moter	NULL
,	NULL
NFAT	NULL
represents	NULL
position	NULL
-280	NULL
to	NULL
B	NULL
-260	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
,	NULL
the	NULL
22501	NULL
-280	NULL
TTAAAGAA	NULL
AGGHNGS	NULL
ACAGARGGCG	NULL
|	NULL
...	NULL
3	NULL
``	NULL
AaTTTCTT	NULL
Toou	NULL
TGTCTTeecec	NULL
|	NULL
...	NULL
5	NULL
!	NULL

NFAT	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
are	NULL
under-	NULL
ZIP	NULL
5	NULL
``	NULL
TCTATCCCCACCCCCTTAACAA	NULL
3	NULL
lined	NULL
,	NULL
NFAT	NULL
Â»	NULL
,	NULL
represents	NULL
a	NULL
mutated	NULL
NFAT	NULL
domain	NULL
,	NULL
the	NULL
mutated	NULL
nucleotides	NULL
are	NULL
underlined	NULL
,	NULL
and	NULL
GC	NULL
,	NULL
includes	NULL
the	NULL
NFAT	NULL
5	NULL
'	NULL
TAAGCAGGAAAAACTGTITTCAT	NULL
3	NULL
boxed	NULL
EGR	NULL
consensus	NULL
binding	NULL
site	NULL
(	NULL
14	NULL
)	NULL
.	NULL

NFATy	NULL
5Â°	NULL
TAAGCGAGGCAAAACTGTTGCATAC	NULL
3	NULL
``	NULL
GC	NULL
;	NULL
5Â°	NULL
3	NULL
Plaque-purified	NULL
EGR-1	NULL
or	NULL
AT133/EGR-4	NULL
baculovirusesÂ®	NULL
were	NULL
prepared	NULL
by	NULL
standard	NULL
methods	NULL
(	NULL
30	NULL
)	NULL
and	NULL
were	NULL
used	NULL
to	NULL
infect	NULL
Sf9	NULL
insect	NULL
cells	NULL
,	NULL
cultivated	NULL
in	NULL
Grace	NULL
's	NULL
medium	NULL
.	NULL

A	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
5	NULL
was	NULL
used	NULL
.	NULL

After	NULL
70	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
three	NULL
freeze-thaw	NULL
cycles	NULL
,	NULL
and	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
sodium	NULL
phosphate	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
400	NULL
mm	NULL
KCl	NULL
,	NULL
10	NULL
uM	NULL
ZnCl	NULL
,	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
contained	NULL
proteinase	NULL
inhibitors	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
,	NULL
leupeptin	NULL
(	NULL
56	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
aprotinin	NULL
(	NULL
56	NULL
ug/ml	NULL
)	NULL
.	NULL

IL-2	NULL
Reporter	NULL
Constructs-Specific	NULL
primers	NULL
were	NULL
used	NULL
for	NULL
polymerase	NULL
chain	NULL
reaction	NULL
amplification	NULL
of	NULL
the	NULL
indicated	NULL
regulatory	NULL
elements	NULL
using	NULL
a	NULL
417-bp	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
region	NULL
.	NULL

Amplified	NULL
fragments	NULL
were	NULL
ligated	NULL
to	NULL
the	NULL
complete	NULL
(	NULL
-253	NULL
to	NULL
+51	NULL
)	NULL
or	NULL
to	NULL
a	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
region	NULL
(	NULL
-63	NULL
to	NULL
+51	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

Primers	NULL
eu5	NULL
(	NULL
tttggtaceCCACAATATGCTATTCACATGTTCA	NULL
,	NULL
position	NULL
-866	NULL
to	NULL
-342	NULL
)	NULL
and	NULL
eu	NULL
)	NULL
(	NULL
tttgageteGCAGGAGTTGAGGTTACT-GTGAGTAG	NULL
,	NULL
+51	NULL
to	NULL
+26	NULL
)	NULL
(	NULL
capital	NULL
letters	NULL
refer	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
sequence	NULL
,	NULL
and	NULL
introduced	NULL
KprI	NULL
and	NULL
Sael	NULL
restriction	NULL
sites	NULL
are	NULL
underlined	NULL
)	NULL
were	NULL
digested	NULL
with	NULL
KpnI	NULL
and	NULL
SacI	NULL
,	NULL
respectively	NULL
and	NULL
ligated	NULL
with	NULL
Kpnl-	NULL
and	NULL
Sacl-treated	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
pGL2-Basic	NULL
Vector	NULL
(	NULL
Promega	NULL
Corp.	NULL
)	NULL
to	NULL
yield	NULL
plasmid	NULL
pClLuel	NULL
.	NULL

Plasmid	NULL
pClLue2	NULL
was	NULL
constructed	NULL
in	NULL
the	NULL
same	NULL
way	NULL
using	NULL
primers	NULL
eu9	NULL
and	NULL
eu6	NULL
(	NULL
tttggatecAGGA-GGAAAAACTGTTTCATACAGA	NULL
,	NULL
-279	NULL
to	NULL
-255	NULL
)	NULL
.	NULL

Additional	NULL
IL-2	NULL
promoter	NULL
fragments	NULL
generated	NULL
with	NULL
primers	NULL
eu9	NULL
and	NULL
eud4	NULL
(	NULL
tttggatecG-GCGTTAATT	NULL
GCATGAATTAGAGC	NULL
,	NULL
-253	NULL
to	NULL
-230	NULL
)	NULL
and	NULL
with	NULL
primers	NULL
eud	NULL
and	NULL
eu8	NULL
(	NULL
tttggatecCATTTTGACACCCCCATAATA	NULL
,	NULL
-68	NULL
to	NULL
-42	NULL
;	NULL
BamHI	NULL
sites	NULL
are	NULL
underlined	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
pCRÂ®II	NULL
vector	NULL
(	NULL
In-vitrogen	NULL
)	NULL
to	NULL
yield	NULL
plasmids	NULL
p4TA	NULL
and	NULL
pOTA	NULL
,	NULL
respectively	NULL
.	NULL

Inserts	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
two	NULL
plasmids	NULL
by	NULL
KpnI	NULL
and	NULL
SacI	NULL
restriction	NULL
and	NULL
were	NULL
ligated	NULL
into	NULL
vector	NULL
pGL2-Basic	NULL
to	NULL
yield	NULL
pClLiued	NULL
(	NULL
-253	NULL
to	NULL
+51	NULL
of	NULL
IL-2	NULL
)	NULL
and	NULL
pMILued4	NULL
(	NULL
-63	NULL
to	NULL
+51	NULL
;	NULL
i.e	NULL
.	NULL

minimal	NULL
IL-2	NULL
promoter	NULL
fragment	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

For	NULL
construction	NULL
of	NULL
pClLuc3	NULL
and	NULL
pMILuc3	NULL
,	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
ZIP	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
sequence	NULL
(	NULL
tttggtaccTGTATCCCCACCCCCTTAAAGAAggatee	NULL
,	NULL
-8302	NULL
to	NULL
-280	NULL
,	NULL
introduced	NULL
KpnI	NULL
and	NULL
BamHI	NULL
restriction	NULL
sites	NULL
are	NULL
underlined	NULL
)	NULL
was	NULL
cleaved	NULL
and	NULL
inserted	NULL
into	NULL
KpmnI-BaomHI-digested	NULL
vectors	NULL
p4TA	NULL
and	NULL
pOTA	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
resulting	NULL
fragments	NULL
were	NULL
excised	NULL
by	NULL
Kpn	NULL
!	NULL

and	NULL
Sacl	NULL
and	NULL
ligated	NULL
into	NULL
pGL2-Basic	NULL
vectors	NULL
.	NULL

To	NULL
engineer	NULL
a	NULL
construct	NULL
with	NULL
ZIP-NFAT	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
region	NULL
,	NULL
a	NULL
restricted	NULL
double-stranded	NULL
oligonucleotide	NULL
covering	NULL
the	NULL
ZIP-NFAT	NULL
sites	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
-302	NULL
to	NULL
-257	NULL
)	NULL
was	NULL
inserted	NULL
into	NULL
vector	NULL
pOTA	NULL
.	NULL

The	NULL
complete	NULL
insert	NULL
was	NULL
excised	NULL
and	NULL
cloned	NULL
into	NULL
a	NULL
KprI-	NULL
,	NULL
Sacl-treated	NULL
pGL2-Basic	NULL
vector	NULL
to	NULL
obtain	NULL
pMILuel1	NULL
.	NULL

For	NULL
plasmid	NULL
pMI-LUC2	NULL
,	NULL
containing	NULL
the	NULL
NFAT	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
sequence	NULL
,	NULL
plasmid	NULL
pMILucl	NULL
was	NULL
used	NULL
as	NULL
template	NULL
for	NULL
polymerase	NULL
chain	NULL
reaction-amplification	NULL
with	NULL
primers	NULL
eu6	NULL
and	NULL
eug	NULL
.	NULL

The	NULL
KpnI-	NULL
,	NULL
Sacl-cleaved	NULL
polymerase	NULL
chain	NULL
reaction	NULL
product	NULL
was	NULL
ligated	NULL
into	NULL
the	NULL
vector	NULL
pGL2-Basic	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
all	NULL
constructs	NULL
was	NULL
confirmed	NULL
by	NULL
restriction	NULL
and	NULL
DNA	NULL
sequence	NULL
analysis	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transfection-The	NULL
human	NULL
helper	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inacti-	NULL
2	NULL
C.	NULL
Skerka	NULL
and	NULL
P.	NULL
F.	NULL
Zipfel	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

vated	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
penicillin	NULL
,	NULL
streptomycin	NULL
,	NULL
and	NULL
fungizone	NULL
at	NULL
a	NULL
cell	NULL
density	NULL
of	NULL
5	NULL
X	NULL
10Â°	NULL
cells/ml	NULL
.	NULL

For	NULL
transient	NULL
transfection	NULL
experiments	NULL
,	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
(	NULL
800	NULL
V	NULL
,	NULL
960	NULL
microfar-ads	NULL
)	NULL
(	NULL
Bio-Rad	NULL
)	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
CsCl-banded	NULL
reporter	NULL
plasmid	NULL
constructs	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
1	NULL
ug/ml	NULL
PHA	NULL
(	NULL
phy-tohemagglutinin	NULL
;	NULL
Burroughs	NULL
Wellcome	NULL
)	NULL
and	NULL
20	NULL
ng/ml	NULL
PMA	NULL
(	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
;	NULL
Sigma	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
by	NULL
washing	NULL
three	NULL
times	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
lysed	NULL
by	NULL
incubation	NULL
in	NULL
250	NULL
ul	NULL
of	NULL
lysis	NULL
reagent	NULL
(	NULL
Promega	NULL
Corp.	NULL
)	NULL
.	NULL

A	NULL
50-ul	NULL
sample	NULL
of	NULL
cell	NULL
lysate	NULL
was	NULL
mixed	NULL
with	NULL
100	NULL
pl	NULL
of	NULL
luciferase	NULL
assay	NULL
reagent	NULL
and	NULL
measured	NULL
immediately	NULL
at	NULL
25	NULL
Â°C	NULL
using	NULL
a	NULL
luminometer	NULL
(	NULL
Berthold	NULL
Biolumat	NULL
LB9500C	NULL
)	NULL
.	NULL

The	NULL
initial	NULL
30-s	NULL
integral	NULL
of	NULL
light	NULL
emission	NULL
was	NULL
recorded	NULL
.	NULL

All	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
and	NULL
Mobility	NULL
Shift	NULL
Assay-Nuclear	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
with	NULL
minor	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
2	NULL
%	NULL
10	NULL
``	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
PHA	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

and	NULL
PMA	NULL
(	NULL
25	NULL
ng/ml	NULL
)	NULL
were	NULL
lysed	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
10	NULL
mm	NULL
KCl	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.15	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.5	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
5	NULL
pg/ml	NULL
aprotinin	NULL
,	NULL
10	NULL
uM	NULL
ZnCl	NULL
,	NULL
.	NULL

Nuclei	NULL
were	NULL
centrifuged	NULL
at	NULL
1,000	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
the	NULL
above	NULL
solution	NULL
without	NULL
Nonidet	NULL
P-40	NULL
.	NULL

3	NULL
M	NULL
KCl	NULL
was	NULL
added	NULL
drop	NULL
by	NULL
drop	NULL
to	NULL
reach	NULL
0.39	NULL
M	NULL
,	NULL
and	NULL
the	NULL
extract	NULL
was	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
Â°C	NULL
.	NULL

Extracts	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
100,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
min	NULL
and	NULL
stored	NULL
at	NULL
-70	NULL
Â°	NULL
C.	NULL
Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
using	NULL
the	NULL
Bradford	NULL
method	NULL
.	NULL

For	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
0.2	NULL
ng	NULL
(	NULL
about	NULL
10	NULL
``	NULL
epm	NULL
)	NULL
of	NULL
*Â°P-end-labeled	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
incubated	NULL
at	NULL
4Â°C	NULL
with	NULL
5-10	NULL
ug	NULL
of	NULL
nuclear	NULL
proteins	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
80	NULL
ng	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
in	NULL
20	NULL
ul	NULL
of	NULL
10	NULL
mm	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
10	NULL
uM	NULL
ZnCl	NULL
,	NULL
,	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
.	NULL

For	NULL
some	NULL
experiments	NULL
,	NULL
EGR-1-	NULL
and	NULL
Spl-specific	NULL
antisera	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
were	NULL
added	NULL
after	NULL
10	NULL
min	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
another	NULL
20	NULL
min	NULL
at	NULL
4	NULL
Â°C	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
separated	NULL
from	NULL
free	NULL
probes	NULL
on	NULL
4-6	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
(	NULL
0.25	NULL
x	NULL
)	NULL
TBE	NULL
at	NULL
4	NULL
Â°C	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
x-ray	NULL
films	NULL
.	NULL

All	NULL
binding	NULL
assays	NULL
were	NULL
repeated	NULL
at	NULL
least	NULL
five	NULL
times	NULL
.	NULL

RNA	NULL
Isolation	NULL
and	NULL
Northern	NULL
Blotting-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
with	NULL
guanidinium	NULL
isothiocyanate	NULL
and	NULL
isolated	NULL
by	NULL
centrifugation	NULL
(	NULL
32	NULL
)	NULL
.	NULL

RNA	NULL
electrophoresis	NULL
and	NULL
transfer	NULL
to	NULL
nylon	NULL
membranes	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
7	NULL
)	NULL
.	NULL

For	NULL
hybridization	NULL
,	NULL
the	NULL
following	NULL
*Â°P-labeled	NULL
fragments	NULL
were	NULL
used	NULL
:	NULL
(	NULL
i	NULL
)	NULL
a	NULL
2.1-kilobase	NULL
cDNA	NULL
insert	NULL
from	NULL
plasmid	NULL
pPacSp1	NULL
covering	NULL
the	NULL
696	NULL
C-terminal	NULL
amino	NULL
acids	NULL
of	NULL
Spl	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
R.	NULL
Tjian	NULL
)	NULL
and	NULL
a	NULL
pAT	NULL
225/EGR-1	NULL
cDNA	NULL
probe	NULL
representing	NULL
a	NULL
429-bp	NULL
SphI-Poull	NULL
fragment	NULL
of	NULL
the	NULL
C-terminal	NULL
part	NULL
(	NULL
position	NULL
1388-1817	NULL
)	NULL
.	NULL

RESULTS	NULL
Binding	NULL
of	NULL
Nuclear	NULL
Proteins	NULL
to	NULL
the	NULL
ZIP	NULL
Element	NULL
of	NULL
the	NULL
Human	NULL
IL-2	NULL
Gene-In	NULL
order	NULL
to	NULL
prove	NULL
whether	NULL
the	NULL
G-rich	NULL
element	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
serves	NULL
as	NULL
binding	NULL
site	NULL
for	NULL
nuclear	NULL
proteins	NULL
,	NULL
a	NULL
corresponding	NULL
oligonucleotide	NULL
was	NULL
used	NULL
for	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
22502	NULL
E	NULL
.	NULL

m	NULL
we	NULL
Competitor	NULL
(	NULL
200x	NULL
)	NULL
-	NULL
-	NULL
Q	NULL
&	NULL
(	NULL
5	NULL
-	NULL
N	NULL
pr	NULL
1	NULL
2	NULL
0	NULL
B	NULL
-	NULL
4	NULL
Vover-	NULL
>	NULL
OPM	NULL
W	NULL
Lower	NULL
``	NULL
Complex	NULL
s	NULL
3	NULL
'	NULL
mere	NULL
Labelled	NULL
probe	NULL
|	NULL
--	NULL
--	NULL
ZIP	NULL
--	NULL
-	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Protein	NULL
complexes	NULL
binding	NULL
to	NULL
the	NULL
ZIP	NULL
(	NULL
position	NULL
-303	NULL
to	NULL
-280	NULL
)	NULL
oligonucleotide	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
nuclear	NULL
protein	NULL
extracts	NULL
prepared	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
PHA	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

and	NULL
PMA	NULL
(	NULL
25	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
2	NULL
h.	NULL
Two	NULL
specific	NULL
complexes	NULL
bound	NULL
to	NULL
the	NULL
radiola-beled	NULL
ZIP	NULL
site	NULL
(	NULL
Upper	NULL
and	NULL
Lower	NULL
complex	NULL
)	NULL
.	NULL

Competition	NULL
with	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
ZIP	NULL
oligonucleotides	NULL
showed	NULL
specificity	NULL
of	NULL
both	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
protein	NULL
complexes	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

Competition	NULL
with	NULL
an	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
EGR	NULL
consensus	NULL
site	NULL
(	NULL
GC	NULL
,	NULL
)	NULL
showed	NULL
specific	NULL
competition	NULL
of	NULL
the	NULL
lower	NULL
band	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
while	NULL
an	NULL
oligonucleotide	NULL
with	NULL
unrelated	NULL
sequence	NULL
(	NULL
NFAT	NULL
,	NULL
,	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
ZIP	NULL
)	NULL
.	NULL

Two	NULL
distinct	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
PMA/PHA-stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
1	NULL
,	NULL
Upper	NULL
and	NULL
Lower	NULL
complex	NULL
)	NULL
.	NULL

Both	NULL
complexes	NULL
were	NULL
specific	NULL
as	NULL
they	NULL
were	NULL
competed	NULL
by	NULL
unlabeled	NULL
ZIP	NULL
oligonucleotides	NULL
(	NULL
lane	NULL
3	NULL
,	NULL
ZIP	NULL
)	NULL
but	NULL
not	NULL
by	NULL
unrelated	NULL
oligonucleotides	NULL
(	NULL
lane	NULL
4	NULL
,	NULL
NFAT	NULL
,	NULL
,	NULL
,	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
representing	NULL
an	NULL
EGR	NULL
consensus	NULL
site	NULL
(	NULL
termed	NULL
GC	NULL
,	NULL
)	NULL
blocked	NULL
formation	NULL
of	NULL
the	NULL
lower	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
2	NULL
,	NULL
GC	NULL
,	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
a	NULL
member	NULL
of	NULL
the	NULL
EGR	NULL
gene	NULL
family	NULL
participates	NULL
in	NULL
binding	NULL
.	NULL

Sensitivity	NULL
of	NULL
both	NULL
complexes	NULL
to	NULL
the	NULL
metal	NULL
chelator	NULL
1,10-phenanthroline	NULL
and	NULL
restoration	NULL
of	NULL
binding	NULL
by	NULL
Zn	NULL
``	NULL
*	NULL
ionsÂ®	NULL
indicated	NULL
that	NULL
zinc	NULL
finger	NULL
proteins	NULL
are	NULL
forming	NULL
the	NULL
two	NULL
complexes	NULL
.	NULL

As	NULL
de	NULL
novo	NULL
protein	NULL
biosynthesis	NULL
is	NULL
critical	NULL
for	NULL
IL-2	NULL
gene	NULL
induction	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
both	NULL
protein	NULL
complexes	NULL
were	NULL
pre-existing	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

In	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
only	NULL
the	NULL
upper	NULL
complex	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
while	NULL
both	NULL
complexes	NULL
were	NULL
detected	NULL
in	NULL
extracts	NULL
prepared	NULL
from	NULL
stimulated	NULL
cells	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

Specific	NULL
antiserum	NULL
was	NULL
used	NULL
for	NULL
further	NULL
differentiation	NULL
and	NULL
identification	NULL
of	NULL
the	NULL
two	NULL
protein	NULL
complexes	NULL
.	NULL

Spl	NULL
and	NULL
EGR-1	NULL
antiserum	NULL
specifically	NULL
interfered	NULL
with	NULL
formation	NULL
of	NULL
the	NULL
two	NULL
complexes	NULL
.	NULL

Antiserum	NULL
directed	NULL
against	NULL
EGR-1	NULL
specifically	NULL
altered	NULL
migration	NULL
of	NULL
the	NULL
lower	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
EGR-1	NULL
gives	NULL
rise	NULL
to	NULL
the	NULL
inducible	NULL
protein	NULL
complex	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
this	NULL
antiserum	NULL
was	NULL
specific	NULL
as	NULL
equivalent	NULL
concentrations	NULL
of	NULL
related	NULL
rabbit	NULL
antisera	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
binding	NULL
.	NULL
``	NULL

Competition	NULL
of	NULL
the	NULL
lower	NULL
,	NULL
induced	NULL
complex	NULL
with	NULL
EGR-specific	NULL
oligonucleotides	NULL
(	NULL
GC	NULL
,	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Zane	NULL
7	NULL
)	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
supershift	NULL
observed	NULL
with	NULL
the	NULL
EGR-1-specific	NULL
antiserum	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
confirmed	NULL
that	NULL
EGR-1	NULL
is	NULL
part	NULL
of	NULL
the	NULL
lower	NULL
complex	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
the	NULL
pre-existing	NULL
complex	NULL
required	NULL
zinc	NULL
ions	NULL
for	NULL
binding	NULL
suggested	NULL
that	NULL
the	NULL
zinc	NULL
finger	NULL
protein	NULL
and	NULL
transcription	NULL
factor	NULL
Spl	NULL
was	NULL
part	NULL
of	NULL
this	NULL
complex	NULL
.	NULL

Antiserum	NULL
directed	NULL
5	NULL
C.	NULL
Skerka	NULL
and	NULL
P.	NULL
F.	NULL
Zipfel	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

Zinc	NULL
Finger	NULL
Binding	NULL
Element	NULL
in	NULL
the	NULL
Human	NULL
IL-2	NULL
Promoter	NULL
Nuclear	NULL
extracts	NULL
un	NULL
induced	NULL
-	NULL
Competitor	NULL
antiserum	NULL
(	NULL
200	NULL
%	NULL
)	NULL
Y	NULL
Â£	NULL
E	NULL
h	NULL
|	NULL
$	NULL
a	NULL
<	NULL
o	NULL
<	NULL
o.~	NULL
wou	NULL
O	NULL
Â¥	NULL
Q	NULL
3	NULL
$	NULL
G	NULL
10	NULL
20	NULL
80	NULL
40	NULL
50060	NULL
7	NULL
go	NULL
gm	NULL
Â«	NULL
mn	NULL
dite	NULL
mm	NULL
crm	NULL
Supershift	NULL
-	NULL
Â»	NULL
SP1	NULL
-	NULL
Â»	NULL
waa	NULL
wan	NULL
wn	NULL
s	NULL
%	NULL
sas	NULL
nis	NULL
=	NULL
Tid	NULL
&	NULL
EGR-1	NULL
-	NULL
Â»	NULL
Free	NULL
probe	NULL
-	NULL
Â»	NULL
--	NULL
-	NULL
ZIP	NULL
--	NULL
-	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Identification	NULL
of	NULL
Spl	NULL
and	NULL
EGR-1	NULL
as	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
ZIP	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
.	NULL

In	NULL
nuclear	NULL
extract	NULL
prepared	NULL
from	NULL
unstimulated	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
upper	NULL
complex	NULL
is	NULL
specifically	NULL
detected	NULL
and	NULL
the	NULL
lower	NULL
complex	NULL
is	NULL
absent	NULL
(	NULL
Fane	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
extract	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
,	NULL
two	NULL
complexes	NULL
are	NULL
detected	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

Specific	NULL
antiserum	NULL
identifies	NULL
Spl	NULL
in	NULL
the	NULL
upper	NULL
complex	NULL
,	NULL
present	NULL
in	NULL
unstimulated	NULL
and	NULL
in	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
,	NULL
and	NULL
EGR-1	NULL
in	NULL
the	NULL
lower	NULL
complex	NULL
of	NULL
extract	NULL
prepared	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
anes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Antibody	NULL
binding	NULL
to	NULL
the	NULL
protein	NULL
complexes	NULL
results	NULL
in	NULL
a	NULL
``	NULL
supershift	NULL
``	NULL
and	NULL
in	NULL
a	NULL
reduction	NULL
in	NULL
mobility	NULL
.	NULL

Competition	NULL
experiments	NULL
confirm	NULL
different	NULL
binding	NULL
specificities	NULL
of	NULL
the	NULL
two	NULL
complexes	NULL
.	NULL

Competition	NULL
with	NULL
unrelated	NULL
oligonucleotides	NULL
(	NULL
NFAT	NULL
and	NULL
NFAT	NULL
,	NULL
,	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
binding	NULL
,	NULL
while	NULL
competition	NULL
with	NULL
an	NULL
oligonucleotide	NULL
displaying	NULL
an	NULL
EGR	NULL
consensus	NULL
site	NULL
(	NULL
GC	NULL
,	NULL
)	NULL
specifically	NULL
interfered	NULL
with	NULL
formation	NULL
of	NULL
the	NULL
lower	NULL
EGR-1-containing	NULL
complex	NULL
.	NULL

Labelled	NULL
probe	NULL
against	NULL
the	NULL
Sp1	NULL
protein	NULL
specifically	NULL
altered	NULL
migration	NULL
of	NULL
the	NULL
upper	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
Sp1	NULL
gives	NULL
rise	NULL
to	NULL
the	NULL
inducible	NULL
protein	NULL
complex	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
Sp1	NULL
binds	NULL
to	NULL
the	NULL
ZIP	NULL
site	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
.	NULL

Previously	NULL
,	NULL
specific	NULL
and	NULL
exclusive	NULL
binding	NULL
to	NULL
G-rich	NULL
consensus	NULL
sequences	NULL
of	NULL
EGR-1	NULL
(	NULL
GCG	NULL
GGG	NULL
GCG	NULL
)	NULL
and	NULL
Sp1	NULL
(	NULL
GGG	NULL
GCG	NULL
GGG	NULL
)	NULL
has	NULL
been	NULL
demonstrated	NULL
for	NULL
EGR-1	NULL
and	NULL
the	NULL
mouse	NULL
homolog	NULL
Zif	NULL
268	NULL
,	NULL
for	NULL
Krox	NULL
20	NULL
,	NULL
the	NULL
mouse	NULL
homolog	NULL
of	NULL
EGR-2	NULL
as	NULL
well	NULL
as	NULL
for	NULL
Sp1	NULL
(	NULL
14	NULL
,	NULL
15	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
the	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
G-rich	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
serves	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
zinc	NULL
finger	NULL
proteins	NULL
Spl	NULL
and	NULL
EGR-1	NULL
.	NULL

Therefore	NULL
,	NULL
this	NULL
region	NULL
was	NULL
termed	NULL
the	NULL
zinc	NULL
finger	NULL
protein	NULL
(	NULL
ZIP	NULL
)	NULL
binding	NULL
site	NULL
.	NULL

Regulation	NULL
and	NULL
Binding	NULL
of	NULL
the	NULL
EGR-1	NULL
and	NULL
Sp1	NULL
Proteins-To	NULL
examine	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
ZIP	NULL
binding	NULL
factors	NULL
in	NULL
more	NULL
detail	NULL
,	NULL
a	NULL
time	NULL
course	NULL
of	NULL
induction	NULL
was	NULL
determined	NULL
on	NULL
the	NULL
mRNA	NULL
and	NULL
on	NULL
the	NULL
protein	NULL
level	NULL
.	NULL

Spl	NULL
mRNA	NULL
was	NULL
found	NULL
synthesized	NULL
in	NULL
unstimulated	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
stimulated	NULL
(	NULL
Zanes	NULL
2-6	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
without	NULL
significant	NULL
modulation	NULL
in	NULL
expression	NULL
levels	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
EGR-1	NULL
messenger	NULL
RNA	NULL
was	NULL
not	NULL
expressed	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
but	NULL
was	NULL
induced	NULL
30	NULL
min	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

mRNA	NULL
transcription	NULL
was	NULL
independent	NULL
of	NULL
protein	NULL
biosynthesis	NULL
(	NULL
cycloheximide	NULL
(	NULL
Chx	NULL
)	NULL
,	NULL
lanes	NULL
7-9	NULL
)	NULL
and	NULL
confirmed	NULL
EGR-1	NULL
as	NULL
an	NULL
immediate	NULL
early	NULL
gene	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
2	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
binding	NULL
assays	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
paralleled	NULL
the	NULL
results	NULL
obtained	NULL
by	NULL
Northern	NULL
blotting	NULL
.	NULL

Sp1	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
ZIP	NULL
site	NULL
was	NULL
constitutive	NULL
,	NULL
equal	NULL
levels	NULL
were	NULL
detected	NULL
in	NULL
unstimulated	NULL
cells	NULL
and	NULL
during	NULL
the	NULL
course	NULL
of	NULL
stimulation	NULL
.	NULL

Again	NULL
the	NULL
product	NULL
of	NULL
the	NULL
immediate	NULL
early	NULL
response	NULL
gene	NULL
EGR-1	NULL
was	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Zinc	NULL
Finger	NULL
Binding	NULL
Element	NULL
in	NULL
the	NULL
Human	NULL
IL-2	NULL
Promoter	NULL
A	NULL
PHa+pmMa	NULL
___	NULL
PHA+PMA	NULL
+	NULL
Chx	NULL
I-	NULL
IT	NULL
I	NULL
O	NULL
0	NULL
OA	NULL
#	NULL
CO	NULL
O	NULL
t	NULL
0	NULL
1o	NULL
Op	NULL
8	NULL
40	NULL
50	NULL
60Â°00	NULL
7	NULL
s	NULL
a	NULL
Sp	NULL
1	NULL
QQ.0	NULL
i	NULL
'	NULL
Â®	NULL
EGR-A1	NULL
B	NULL
Nuclear	NULL
extracts	NULL
un	NULL
induced	NULL
Ess	NULL
-	NULL
-C	NULL
Ess	NULL
-C	NULL
iq	NULL
omo	NULL
alo	NULL
so	NULL
oo	NULL
(	NULL
es	NULL
a=	NULL
ed	NULL
1o	NULL
2	NULL
8	NULL
40	NULL
50	NULL
6	NULL
-o	NULL
oh	NULL
t	NULL
>	NULL
G	NULL
-*	NULL
a*	NULL
Labelled	NULL
probe	NULL
_	NULL
|	NULL
--	NULL
--	NULL
--	NULL
ZIP	NULL
--	NULL
--	NULL
--	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Regulation	NULL
of	NULL
Spl	NULL
and	NULL
EGR-1	NULL
expression	NULL
in	NULL
the	NULL
human	NULL
helper	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
.	NULL

A	NULL
,	NULL
Northern	NULL
blot	NULL
analyses	NULL
demonstrates	NULL
constitutive	NULL
expression	NULL
of	NULL
Spl	NULL
mRNA	NULL
in	NULL
the	NULL
human	NULL
helper	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

EGR-1	NULL
mRNA	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
but	NULL
is	NULL
detected	NULL
upon	NULL
stimulation	NULL
with	NULL
PHA	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

and	NULL
PMA	NULL
(	NULL
25	NULL
ng/ml	NULL
)	NULL
(	NULL
Fower	NULL
panel	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
0	NULL
h	NULL
)	NULL
or	NULL
from	NULL
cells	NULL
stimulated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
cycloheximide	NULL
(	NULL
CAx	NULL
;	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

Rehybrid-ization	NULL
of	NULL
the	NULL
filters	NULL
with	NULL
an	NULL
actin	NULL
cDNA	NULL
probe	NULL
showed	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
RNA	NULL
were	NULL
loaded	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

B	NULL
,	NULL
the	NULL
upper	NULL
Spl-containing	NULL
complex	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
lower	NULL
EGR-l-containing	NULL
complex	NULL
is	NULL
transiently	NULL
induced	NULL
upon	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

Binding	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
6	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
prepared	NULL
from	NULL
untreated	NULL
Jurkat	NULL
cells	NULL
or	NULL
from	NULL
cells	NULL
treated	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

A	NULL
*Â°P-labeled	NULL
ZIP	NULL
oligonucleotide	NULL
was	NULL
used	NULL
for	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

transiently	NULL
expressed	NULL
,	NULL
and	NULL
binding	NULL
was	NULL
detected	NULL
1	NULL
and	NULL
2	NULL
h	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Later	NULL
time	NULL
points	NULL
did	NULL
not	NULL
show	NULL
any	NULL
EGR-1	NULL
protein	NULL
complex	NULL
formation	NULL
(	NULL
Zanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
constitutive	NULL
expression	NULL
of	NULL
Sp1	NULL
and	NULL
transient	NULL
synthesis	NULL
of	NULL
EGR-1	NULL
following	NULL
cell	NULL
stimulation	NULL
was	NULL
detected	NULL
on	NULL
the	NULL
RNA	NULL
level	NULL
and	NULL
in	NULL
the	NULL
protein	NULL
binding	NULL
assays	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
no	NULL
additional	NULL
band	NULL
was	NULL
detected	NULL
when	NULL
both	NULL
proteins	NULL
Sp1	NULL
and	NULL
EGR-1	NULL
were	NULL
present	NULL
in	NULL
the	NULL
same	NULL
nuclear	NULL
extract	NULL
suggests	NULL
that	NULL
EGR-1	NULL
competes	NULL
with	NULL
Sp1	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
ZIP	NULL
site	NULL
and	NULL
replaces	NULL
Sp1	NULL
.	NULL

Binding	NULL
Specificities	NULL
of	NULL
EGR-1	NULL
and	NULL
pAT133/EGR-4-We	NULL
asked	NULL
whether	NULL
the	NULL
lower	NULL
complex	NULL
was	NULL
represented	NULL
by	NULL
a	NULL
single	NULL
EGR-1	NULL
protein	NULL
or	NULL
by	NULL
a	NULL
complex	NULL
of	NULL
proteins	NULL
including	NULL
EGR-1	NULL
.	NULL

Determining	NULL
the	NULL
binding	NULL
of	NULL
recombinant	NULL
,	NULL
baculovirus-expressed	NULL
EGR-1	NULL
protein	NULL
to	NULL
the	NULL
ZIP	NULL
oligonucleotide	NULL
resulted	NULL
in	NULL
one	NULL
specific	NULL
shifted	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
showed	NULL
the	NULL
same	NULL
binding	NULL
specificities	NULL
as	NULL
the	NULL
induced	NULL
complex	NULL
detected	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
as	NULL
it	NULL
was	NULL
competed	NULL
with	NULL
unlabeled	NULL
ZIP	NULL
oligonucleotides	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
3	NULL
,	NULL
with	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
but	NULL
not	NULL
with	NULL
an	NULL
unrelated	NULL
NFAT	NULL
oligonucleotide	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
2	NULL
,	NULL
with	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
antiserum	NULL
raised	NULL
against	NULL
EGR-1	NULL
,	NULL
but	NULL
not	NULL
EGR-3	NULL
antiserum	NULL
,	NULL
abolished	NULL
binding	NULL
of	NULL
the	NULL
recombinant	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
binding	NULL
of	NULL
recombinant	NULL
EGR-1	NULL
seems	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
additional	NULL
T	NULL
cell-specific	NULL
transcription	NULL
factors	NULL
.	NULL

Upon	NULL
activation	NULL
of	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
transcription	NULL
of	NULL
the	NULL
22503	NULL
&	NULL
x9	NULL
AA	NULL
o	NULL
=s	NULL
6520+	NULL
.	NULL

$	NULL
CW	NULL
S	NULL
&	NULL
&	NULL
&	NULL
|	NULL
z	NULL
1	NULL
1	NULL
62	NULL
Â§	NULL
Â§	NULL
<	NULL
&	NULL
z	NULL
N-	NULL
g	NULL
LU	NULL
3	NULL
3	NULL
Recombinant	NULL
EGR-1	NULL
(	NULL
Â£251,313	NULL
)	NULL
proteins	NULL
Complex	NULL
-	NULL
Â»	NULL
a	NULL
!	NULL

c	NULL
us	NULL
SORP	NULL
ien	NULL
!	NULL

Free	NULL
probe	NULL
-	NULL
Â»	NULL
Labelled	NULL
probe	NULL
|	NULL
ZIP	NULL
|	NULL
--	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Recombinant	NULL
EGR-1	NULL
protein	NULL
binds	NULL
to	NULL
the	NULL
ZIP	NULL
oligonucleotide	NULL
(	NULL
position	NULL
-303	NULL
to	NULL
-280	NULL
)	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Binding	NULL
of	NULL
recombinant	NULL
EGR-1	NULL
,	NULL
expressed	NULL
in	NULL
the	NULL
baculovirus	NULL
expression	NULL
system	NULL
to	NULL
the	NULL
ZIP	NULL
oligonucleotide	NULL
(	NULL
position	NULL
-303	NULL
to	NULL
-280	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
)	NULL
.	NULL

Binding	NULL
was	NULL
assessed	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
,	NULL
unspecific	NULL
(	NULL
Zane	NULL
2	NULL
,	NULL
NFAT	NULL
)	NULL
or	NULL
specific	NULL
(	NULL
lane	NULL
3	NULL
,	NULL
ZIP	NULL
)	NULL
competitor	NULL
DNA	NULL
.	NULL

Antiserum	NULL
raised	NULL
against	NULL
EGR-1	NULL
affected	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
while	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
related	NULL
zinc	NULL
finger	NULL
protein	NULL
EGR-3	NULL
showed	NULL
no	NULL
effect	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
EGR-1	NULL
,	NULL
recombinant	NULL
ATI133/EGR-4	NULL
protein	NULL
,	NULL
also	NULL
prepared	NULL
in	NULL
baculovirus-infected	NULL
insect	NULL
cells	NULL
,	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
ZIP	NULL
oligonucleotide	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
recombinant	NULL
AT133/EGR-4	NULL
protein	NULL
bound	NULL
to	NULL
the	NULL
GC	NULL
,	NULL
oligonucleotide	NULL
,	NULL
which	NULL
includes	NULL
a	NULL
consensus	NULL
site	NULL
for	NULL
the	NULL
EGR	NULL
proteins	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

four	NULL
known	NULL
EGR	NULL
genes	NULL
is	NULL
simultaneously	NULL
and	NULL
coordinately	NULL
induced	NULL
(	NULL
7	NULL
)	NULL
,	NULL
and	NULL
binding	NULL
to	NULL
the	NULL
consensus	NULL
site	NULL
(	NULL
GC	NULL
;	NULL
)	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
vitro	NULL
for	NULL
the	NULL
corresponding	NULL
proteins	NULL
(	NULL
4-6	NULL
,	NULL
13-18	NULL
)	NULL
.	NULL

As	NULL
the	NULL
ZIP	NULL
sequence	NULL
differs	NULL
from	NULL
the	NULL
known	NULL
EGR	NULL
consensus	NULL
site	NULL
,	NULL
we	NULL
addressed	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
other	NULL
EGR	NULL
proteins	NULL
could	NULL
bind	NULL
to	NULL
this	NULL
promoter	NULL
element	NULL
.	NULL

No	NULL
binding	NULL
of	NULL
baculovirus-expressed	NULL
AT133/EGR-4	NULL
protein	NULL
was	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
although	NULL
the	NULL
recombinant	NULL
AT133/EGR-4	NULL
protein	NULL
recognized	NULL
the	NULL
EGR	NULL
consensus	NULL
site	NULL
(	NULL
Zane	NULL
7	NULL
;	NULL
GC	NULL
;	NULL
)	NULL
.	NULL

This	NULL
result	NULL
demonstrates	NULL
different	NULL
binding	NULL
specificities	NULL
of	NULL
the	NULL
highly	NULL
related	NULL
zinc	NULL
finger	NULL
proteins	NULL
EGR-1	NULL
and	NULL
AT133/EGR-4	NULL
.	NULL

Preferential	NULL
binding	NULL
of	NULL
EGR-1	NULL
to	NULL
the	NULL
ZIP	NULL
region	NULL
was	NULL
also	NULL
strengthened	NULL
by	NULL
the	NULL
use	NULL
of	NULL
antisera	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
antisera	NULL
against	NULL
EGR-1	NULL
,	NULL
but	NULL
not	NULL
antisera	NULL
specific	NULL
for	NULL
EGR-2	NULL
,	NULL
EGR-3	NULL
,	NULL
and	NULL
AT133/	NULL
EGR-4	NULL
,	NULL
did	NULL
interfere	NULL
with	NULL
formation	NULL
of	NULL
the	NULL
induced	NULL
complex.Â®	NULL
Regulation	NULL
of	NULL
Gene	NULL
Expression-The	NULL
in	NULL
vivo	NULL
significance	NULL
of	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
22504	NULL
the	NULL
ZIP	NULL
site	NULL
on	NULL
IL-2	NULL
gene	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
transfection	NULL
experiments	NULL
.	NULL

Various	NULL
hybrid	NULL
plasmid	NULL
constructs	NULL
containing	NULL
the	NULL
ZIP	NULL
and	NULL
NFAT	NULL
sites	NULL
with	NULL
a	NULL
regular	NULL
or	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
were	NULL
linked	NULL
to	NULL
the	NULL
firefly	NULL
luciferase	NULL
(	NULL
Luc	NULL
)	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Upon	NULL
transient	NULL
transfection	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
individual	NULL
constructs	NULL
responded	NULL
differently	NULL
to	NULL
T	NULL
lymphocyte	NULL
activation	NULL
signals	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

The	NULL
complete	NULL
IL-2	NULL
reporter	NULL
gene	NULL
construct	NULL
pCILuecl	NULL
(	NULL
-366	NULL
to	NULL
+51	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
displayed	NULL
regulatory	NULL
activities	NULL
characteristic	NULL
for	NULL
the	NULL
endogenous	NULL
IL-2	NULL
gene	NULL
:	NULL
it	NULL
was	NULL
inactive	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
but	NULL
luciferase	NULL
activity	NULL
was	NULL
induced	NULL
96-fold	NULL
by	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

This	NULL
induction	NULL
was	NULL
abrogated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cyclosporin	NULL
A	NULL
.	NULL

*	NULL
The	NULL
minimal	NULL
activity	NULL
of	NULL
construct	NULL
pCILue4	NULL
(	NULL
-253	NULL
to	NULL
+51	NULL
)	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
previously	NULL
identified	NULL
binding	NULL
sites	NULL
for	NULL
Oct-1	NULL
,	NULL
NF-	NULL
Â«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
CD28RE	NULL
,	NULL
NRE	NULL
,	NULL
and	NULL
Ets	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

24	NULL
)	NULL
,	NULL
shows	NULL
the	NULL
importance	NULL
of	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
ZIP	NULL
and	NULL
the	NULL
NFAT	NULL
sites	NULL
for	NULL
IL-2	NULL
gene	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

The	NULL
high	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
NFAT-containing	NULL
construct	NULL
(	NULL
pCILuc2	NULL
)	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
34	NULL
)	NULL
and	NULL
underlines	NULL
the	NULL
critical	NULL
role	NULL
of	NULL
NFAT	NULL
for	NULL
IL-2	NULL
gene	NULL
induction	NULL
.	NULL

A	NULL
single	NULL
ZIP	NULL
site	NULL
(	NULL
pClLuc3	NULL
)	NULL
increased	NULL
promoter	NULL
activity	NULL
3-fold	NULL
and	NULL
enhanced	NULL
promoter	NULL
activity	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
NFAT	NULL
site	NULL
(	NULL
pCILucl	NULL
)	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
regulatory	NULL
effects	NULL
by	NULL
transcription	NULL
factors	NULL
binding	NULL
between	NULL
the	NULL
NFAT	NULL
site	NULL
and	NULL
position	NULL
-63	NULL
,	NULL
the	NULL
transcriptional	NULL
role	NULL
of	NULL
the	NULL
NFAT	NULL
or	NULL
ZIP	NULL
site	NULL
was	NULL
also	NULL
tested	NULL
in	NULL
front	NULL
of	NULL
a	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
(	NULL
pMILue4	NULL
;	NULL
-63	NULL
to	NULL
+51	NULL
)	NULL
.	NULL

A	NULL
single	NULL
NFAT	NULL
or	NULL
ZIP	NULL
element	NULL
(	NULL
pMILuc2	NULL
and	NULL
pMILuc3	NULL
)	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
pMILuc4	NULL
,	NULL
2.2-	NULL
and	NULL
4.2-fold	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

The	NULL
20-fold	NULL
increase	NULL
in	NULL
activity	NULL
obtained	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
one	NULL
ZIP	NULL
with	NULL
a	NULL
single	NULL
NFAT	NULL
site	NULL
highlights	NULL
the	NULL
role	NULL
of	NULL
the	NULL
ZIP	NULL
and	NULL
NFAT	NULL
binding	NULL
factors	NULL
in	NULL
IL-2	NULL
gene	NULL
expression	NULL
and	NULL
suggests	NULL
synergism	NULL
of	NULL
action	NULL
.	NULL

DISCUSSION	NULL
The	NULL
current	NULL
study	NULL
identified	NULL
a	NULL
novel	NULL
protein	NULL
binding	NULL
region	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
promoter	NULL
,	NULL
which	NULL
has	NULL
a	NULL
regulatory	NULL
function	NULL
in	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Two	NULL
zinc	NULL
finger	NULL
proteins	NULL
Sp1	NULL
and	NULL
EGR-1	NULL
were	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
this	NULL
element	NULL
.	NULL

In	NULL
unstimulated	NULL
and	NULL
in	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
Sp1	NULL
binds	NULL
to	NULL
this	NULL
region	NULL
,	NULL
while	NULL
in	NULL
activated	NULL
cells	NULL
the	NULL
transiently	NULL
induced	NULL
EGR-1	NULL
protein	NULL
binds	NULL
this	NULL
element	NULL
.	NULL

Due	NULL
to	NULL
binding	NULL
of	NULL
two	NULL
differently	NULL
regulated	NULL
zinc	NULL
finger	NULL
proteins	NULL
,	NULL
this	NULL
binding	NULL
site	NULL
was	NULL
termed	NULL
the	NULL
zinc	NULL
finger	NULL
protein	NULL
binding	NULL
region	NULL
(	NULL
ZIP	NULL
)	NULL
.	NULL

By	NULL
transfection	NULL
experiments	NULL
,	NULL
a	NULL
regulatory	NULL
function	NULL
of	NULL
the	NULL
ZIP	NULL
site	NULL
for	NULL
IL-2	NULL
gene	NULL
induction	NULL
was	NULL
demonstrated	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
PHA/PMA-stimulated	NULL
cells	NULL
,	NULL
the	NULL
ZIP	NULL
site	NULL
activated	NULL
gene	NULL
expression	NULL
,	NULL
particularly	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
NFAT	NULL
region	NULL
.	NULL

The	NULL
ZIP	NULL
site	NULL
seems	NULL
conserved	NULL
in	NULL
evolution	NULL
as	NULL
a	NULL
highly	NULL
related	NULL
element	NULL
is	NULL
located	NULL
in	NULL
the	NULL
same	NULL
orientation	NULL
in	NULL
the	NULL
mouse	NULL
IL-2	NULL
gene	NULL
promoter	NULL
(	NULL
position	NULL
-298	NULL
to	NULL
-290	NULL
)	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
conservation	NULL
of	NULL
the	NULL
ZIP	NULL
and	NULL
NFAT	NULL
domains	NULL
in	NULL
sequence	NULL
and	NULL
in	NULL
location	NULL
in	NULL
both	NULL
the	NULL
human	NULL
and	NULL
the	NULL
mouse	NULL
IL-2	NULL
gene	NULL
promoter	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
proposed	NULL
role	NULL
of	NULL
this	NULL
element	NULL
in	NULL
IL-2	NULL
gene	NULL
regulation	NULL
.	NULL

Although	NULL
the	NULL
ZIP	NULL
site	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
does	NULL
not	NULL
display	NULL
a	NULL
typical	NULL
binding	NULL
site	NULL
for	NULL
Sp1	NULL
or	NULL
EGR-1	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
both	NULL
zinc	NULL
finger	NULL
proteins	NULL
bind	NULL
to	NULL
this	NULL
site	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
Spl	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
EGR	NULL
consensus	NULL
sequence	NULL
(	NULL
35-38	NULL
)	NULL
,	NULL
and	NULL
,	NULL
similarly	NULL
,	NULL
no	NULL
binding	NULL
of	NULL
EGR-1	NULL
to	NULL
the	NULL
Sp1	NULL
consensus	NULL
sequence	NULL
was	NULL
observed	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Despite	NULL
this	NULL
specificity	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
corresponding	NULL
consensus	NULL
se-quences	NULL
,	NULL
binding	NULL
to	NULL
a	NULL
range	NULL
of	NULL
different	NULL
sites	NULL
has	NULL
been	NULL
described	NULL
for	NULL
Spl	NULL
as	NULL
well	NULL
as	NULL
for	NULL
EGR-1	NULL
(	NULL
14	NULL
,	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
there	NULL
*E.	NULL
Decker	NULL
,	NULL
C.	NULL
Skerka	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Zipfel	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

Zinc	NULL
Finger	NULL
Binding	NULL
Element	NULL
in	NULL
the	NULL
Human	NULL
IL-2	NULL
Promoter	NULL
is	NULL
exclusive	NULL
binding	NULL
of	NULL
either	NULL
Sp1	NULL
or	NULL
EGR-1	NULL
to	NULL
the	NULL
ZIP	NULL
site	NULL
,	NULL
as	NULL
the	NULL
mobilities	NULL
of	NULL
the	NULL
factors	NULL
remained	NULL
unchanged	NULL
,	NULL
when	NULL
both	NULL
proteins	NULL
were	NULL
present	NULL
in	NULL
the	NULL
nuclear	NULL
extract	NULL
at	NULL
the	NULL
same	NULL
time	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
unchanged	NULL
mobility	NULL
of	NULL
both	NULL
complexes	NULL
are	NULL
also	NULL
in	NULL
agreement	NULL
with	NULL
this	NULL
explanation	NULL
.	NULL

Overlapping	NULL
EGR-1	NULL
and	NULL
Sp1	NULL
binding	NULL
sites	NULL
as	NULL
described	NULL
here	NULL
for	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
seem	NULL
to	NULL
be	NULL
of	NULL
general	NULL
physiological	NULL
relevance	NULL
,	NULL
as	NULL
similar	NULL
regions	NULL
were	NULL
identified	NULL
recently	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
EGR-1	NULL
(	NULL
15	NULL
)	NULL
,	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
Â«	NULL
(	NULL
19	NULL
)	NULL
,	NULL
the	NULL
mouse	NULL
adenosine/deaminase	NULL
(	NULL
39	NULL
)	NULL
,	NULL
and	NULL
the	NULL
mouse	NULL
thrombospondin	NULL
1	NULL
gene	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
competitive	NULL
binding	NULL
of	NULL
these	NULL
two	NULL
distinct	NULL
zinc	NULL
finger	NULL
proteins	NULL
seems	NULL
to	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
gene	NULL
regulation	NULL
.	NULL

Further	NULL
experiments	NULL
will	NULL
clarify	NULL
whether	NULL
other	NULL
Sp1	NULL
elements	NULL
,	NULL
found	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
gene	NULL
promoters	NULL
,	NULL
can	NULL
serve	NULL
as	NULL
binding	NULL
sites	NULL
and	NULL
regulatory	NULL
domains	NULL
for	NULL
inducible	NULL
EGR	NULL
proteins	NULL
.	NULL

For	NULL
the	NULL
ZIP	NULL
element	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
we	NULL
could	NULL
demonstrate	NULL
preferential	NULL
binding	NULL
of	NULL
EGR-1	NULL
but	NULL
not	NULL
of	NULL
AT133/EGR-4	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
time	NULL
that	NULL
different	NULL
binding	NULL
specificities	NULL
are	NULL
reported	NULL
for	NULL
two	NULL
members	NULL
of	NULL
this	NULL
protein	NULL
family	NULL
.	NULL

Although	NULL
all	NULL
four	NULL
members	NULL
of	NULL
the	NULL
EGR	NULL
zinc	NULL
finger	NULL
gene	NULL
family	NULL
are	NULL
coordinately	NULL
induced	NULL
upon	NULL
mitogenic	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
binding	NULL
of	NULL
the	NULL
individual	NULL
proteins	NULL
to	NULL
their	NULL
target	NULL
sequences	NULL
seems	NULL
tightly	NULL
regulated	NULL
.	NULL

Specificity	NULL
of	NULL
binding	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
binding	NULL
to	NULL
slightly	NULL
modified	NULL
target	NULL
sequences	NULL
or	NULL
by	NULL
interactions	NULL
with	NULL
factors	NULL
binding	NULL
in	NULL
close	NULL
proximity	NULL
of	NULL
the	NULL
identified	NULL
binding	NULL
region	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
the	NULL
ZIP	NULL
site	NULL
on	NULL
IL-2	NULL
gene	NULL
expression	NULL
was	NULL
demonstrated	NULL
in	NULL
vivo	NULL
by	NULL
transfection	NULL
experiments	NULL
using	NULL
plasmid	NULL
constructs	NULL
containing	NULL
the	NULL
ZIP	NULL
and	NULL
NFAT	NULL
site	NULL
with	NULL
a	NULL
regular	NULL
or	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

The	NULL
complete	NULL
IL-2	NULL
reporter	NULL
gene	NULL
construct	NULL
pCILucl	NULL
displayed	NULL
regulatory	NULL
activities	NULL
characteristic	NULL
of	NULL
the	NULL
endogenous	NULL
IL-2	NULL
gene	NULL
,	NULL
and	NULL
induction	NULL
was	NULL
completely	NULL
abrogated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cyclosporin	NULL
A	NULL
.	NULL

The	NULL
previously	NULL
identified	NULL
binding	NULL
sites	NULL
for	NULL
Oct-1	NULL
,	NULL
NF-	NULL
Â«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
CD28RE	NULL
,	NULL
NRE	NULL
,	NULL
and	NULL
Ets	NULL
are	NULL
all	NULL
included	NULL
in	NULL
construct	NULL
pCllLued4	NULL
.	NULL

However	NULL
,	NULL
the	NULL
low	NULL
activity	NULL
obtained	NULL
with	NULL
this	NULL
construct	NULL
demonstrates	NULL
that	NULL
these	NULL
sites	NULL
alone	NULL
have	NULL
a	NULL
minimal	NULL
effect	NULL
on	NULL
transcription	NULL
.	NULL

The	NULL
high	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
NFAT-containing	NULL
construct	NULL
(	NULL
pCILuc2	NULL
)	NULL
demonstrates	NULL
the	NULL
important	NULL
role	NULL
of	NULL
this	NULL
regulatory	NULL
element	NULL
for	NULL
IL-2	NULL
gene	NULL
induction	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
single	NULL
ZIP	NULL
element	NULL
(	NULL
pCILuc3	NULL
)	NULL
increased	NULL
promoter	NULL
activity	NULL
;	NULL
however	NULL
,	NULL
in	NULL
context	NULL
with	NULL
the	NULL
regular	NULL
IL-2	NULL
promoter	NULL
,	NULL
the	NULL
activating	NULL
effect	NULL
of	NULL
a	NULL
single	NULL
NFAT	NULL
region	NULL
was	NULL
more	NULL
pronounced	NULL
than	NULL
that	NULL
of	NULL
a	NULL
single	NULL
ZIP	NULL
site	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
activity	NULL
observed	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
two	NULL
sites	NULL
(	NULL
pCILiuc1	NULL
)	NULL
suggests	NULL
an	NULL
additive	NULL
effect	NULL
of	NULL
the	NULL
binding	NULL
proteins	NULL
.	NULL

A	NULL
regulatory	NULL
activity	NULL
of	NULL
the	NULL
ZIP	NULL
and	NULL
NFAT	NULL
elements	NULL
and	NULL
a	NULL
possible	NULL
interaction	NULL
of	NULL
the	NULL
binding	NULL
factors	NULL
are	NULL
confirmed	NULL
from	NULL
the	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
constructs	NULL
.	NULL

Regulatory	NULL
effects	NULL
by	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
identified	NULL
sites	NULL
located	NULL
between	NULL
the	NULL
NFAT	NULL
site	NULL
and	NULL
position	NULL
-63	NULL
were	NULL
ruled	NULL
out	NULL
by	NULL
analyzing	NULL
the	NULL
NFAT	NULL
or	NULL
ZIP	NULL
sites	NULL
in	NULL
front	NULL
of	NULL
a	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
(	NULL
pMILuc4	NULL
;	NULL
-63	NULL
to	NULL
+51	NULL
)	NULL
.	NULL

A	NULL
single	NULL
NFAT	NULL
or	NULL
ZIP	NULL
element	NULL
(	NULL
pMILuc2	NULL
and	NULL
pMILuc3	NULL
)	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
pMILuc4	NULL
,	NULL
2.2-	NULL
and	NULL
4.0-fold	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

The	NULL
20-fold	NULL
increase	NULL
in	NULL
activity	NULL
obtained	NULL
by	NULL
an	NULL
IL-2	NULL
promoter	NULL
element	NULL
including	NULL
the	NULL
NFAT	NULL
and	NULL
the	NULL
ZIP	NULL
site	NULL
,	NULL
highlights	NULL
the	NULL
role	NULL
of	NULL
the	NULL
ZIP	NULL
and	NULL
NFAT	NULL
binding	NULL
factors	NULL
in	NULL
IL-2	NULL
gene	NULL
expression	NULL
and	NULL
suggests	NULL
synergism	NULL
of	NULL
action	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
protein	NULL
EGR-1	NULL
to	NULL
the	NULL
ZIP	NULL
site	NULL
was	NULL
demonstrated	NULL
in	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
EGR-1	NULL
protein	NULL
functions	NULL
as	NULL
a	NULL
positive	NULL
regulator	NULL
of	NULL
IL-2	NULL
gene	NULL
transcription	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
EGR-1	NULL
can	NULL
function	NULL
equally	NULL
well	NULL
as	NULL
an	NULL
activator	NULL
and	NULL
repressor	NULL
of	NULL
gene	NULL
expression	NULL
(	NULL
5	NULL
,	NULL
14	NULL
,	NULL
15	NULL
,	NULL
19	NULL
,	NULL
39	NULL
,	NULL
40	NULL
)	NULL
,	NULL
and	NULL
different	NULL
functional	NULL
domains	NULL
have	NULL
been	NULL
localized	NULL
within	NULL
the	NULL
protein	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
close	NULL
proximity	NULL
of	NULL
the	NULL
ZIP	NULL
and	NULL
NFAT	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Zinc	NULL
Finger	NULL
Binding	NULL
Element	NULL
in	NULL
the	NULL
Human	NULL
IL-2	NULL
Promoter	NULL
22505	NULL
A	NULL
pCiLue1	NULL
_	NULL
|_	NULL
|_	NULL
_____	NULL
<	NULL
+366	NULL
+10	NULL
451	NULL
I	NULL
IL-2	NULL
A	NULL
Lug-pCiLuc2	NULL
53	NULL
+253	NULL
+10	NULL
+51	NULL
pCitues	NULL
|__	NULL
[	NULL
Â®	NULL
)	NULL
|_|	NULL
___	NULL
<	NULL
+258	NULL
+1	NULL
.	NULL

+51	NULL
a	NULL
emmm	NULL
|	NULL
--	NULL
>	NULL
253	NULL
+10	NULL
+51	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

The	NULL
ZIP	NULL
and	NULL
NFAT	NULL
sites	NULL
regulate	NULL
gene	NULL
expression	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
p	NULL
â	NULL
representation	NULL
of	NULL
the	NULL
IL-2/luciferase	NULL
gene	NULL
pMiILuci	NULL
efx	NULL
]	NULL
es	NULL
51	NULL
hybrids	NULL
used	NULL
for	NULL
transient	NULL
transfections	NULL
.	NULL

A	NULL
366-bp	NULL
fragment	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
and	NULL
deletions	NULL
thereof	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
(	NULL
Luc	NULL
)	NULL
.	NULL

Con-	NULL
pMILuc2	NULL
|eear	NULL
|	NULL
-	NULL
â	NULL
structs	NULL
pClLuel-4	NULL
include	NULL
a	NULL
regular	NULL
IL-2	NULL
690	NULL
+f	NULL
a51	NULL
promoter	NULL
(	NULL
position	NULL
-253	NULL
to	NULL
+51	NULL
)	NULL
,	NULL
while	NULL
constructs	NULL
pMILuel-4	NULL
have	NULL
the	NULL
tested	NULL
regulatory	NULL
elements	NULL
linked	NULL
to	NULL
a	NULL
minimal	NULL
pMILuc3	NULL
[	NULL
ar	NULL
-	NULL
â	NULL
IL-2	NULL
promoter	NULL
(	NULL
-63	NULL
to	NULL
+51	NULL
)	NULL
.	NULL

The	NULL
ZIP	NULL
and	NULL
Â«	NULL
6300	NULL
+10	NULL
+51	NULL
NFAT	NULL
binding	NULL
regions	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

For	NULL
construction	NULL
details	NULL
,	NULL
see	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

B	NULL
,	NULL
Jurkat	NULL
MiLuc4	NULL
$	NULL
3	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indi-	NULL
pMEuc	NULL
cated	NULL
plasmids	NULL
by	NULL
electroporation	NULL
.	NULL

After	NULL
(	NULL
69	NULL
+10	NULL
a81	NULL
24	NULL
h	NULL
,	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
stimu-	NULL
-	NULL
IL-2	NULL
--	NULL
-	NULL
Lug-lated	NULL
with	NULL
PHA	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
and	NULL
PMA	NULL
(	NULL
25	NULL
ng/ml	NULL
)	NULL
,	NULL
and	NULL
,	NULL
24	NULL
h	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
B	NULL
and	NULL
luciferase	NULL
activity	NULL
of	NULL
the	NULL
cell	NULL
lysate	NULL
pCiLued	NULL
100,0	NULL
%	NULL
was	NULL
determined	NULL
.	NULL

Luciferase	NULL
activity	NULL
obtained	NULL
with	NULL
constructs	NULL
(	NULL
pClLucl	NULL
and	NULL
pMILuc1	NULL
)	NULL
,	NULL
which	NULL
include	NULL
a	NULL
single	NULL
ZIP	NULL
and	NULL
pCllLuc2	NULL
69,8	NULL
%	NULL
a	NULL
single	NULL
NFAT	NULL
site	NULL
,	NULL
was	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

Luciferase	NULL
activity	NULL
of	NULL
each	NULL
set	NULL
of	NULL
constructs	NULL
0	NULL
is	NULL
shown	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
con-	NULL
21,7	NULL
%	NULL
struct	NULL
pClLuel	NULL
or	NULL
pMILuel	NULL
.	NULL

Each	NULL
column	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
five	NULL
independent	NULL
o	NULL
experiments	NULL
,	NULL
and	NULL
standard	NULL
deviations	NULL
are	NULL
pCilLued4	NULL
1,8	NULL
%	NULL
indicated	NULL
by	NULL
bars	NULL
.	NULL

pMILuc1	NULL
100,0	NULL
%	NULL
pMILuc2	NULL
13,4	NULL
%	NULL
pMILuc3	NULL
19,0	NULL
%	NULL
pMILuc4	NULL
4,8	NULL
%	NULL
combination	NULL
with	NULL
the	NULL
experimental	NULL
results	NULL
suggests	NULL
an	NULL
interaction	NULL
between	NULL
their	NULL
binding	NULL
factors	NULL
.	NULL

Several	NULL
proteins	NULL
which	NULL
are	NULL
regulated	NULL
differently	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
NFAT	NULL
element	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

NFAT	NULL
is	NULL
composed	NULL
of	NULL
a	NULL
pre-existing	NULL
cytoplas-mic	NULL
component	NULL
(	NULL
NFATe/p	NULL
)	NULL
that	NULL
translocates	NULL
into	NULL
the	NULL
nucleus	NULL
upon	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
25	NULL
,	NULL
29	NULL
,	NULL
44	NULL
)	NULL
.	NULL

There	NULL
it	NULL
interacts	NULL
with	NULL
the	NULL
Luciferase	NULL
activity	NULL
(	NULL
%	NULL
)	NULL
ubiquitous	NULL
,	NULL
newly	NULL
synthesized	NULL
AP-1	NULL
component	NULL
to	NULL
form	NULL
a	NULL
protein	NULL
complex	NULL
.	NULL

Neither	NULL
the	NULL
two	NULL
recently	NULL
cloned	NULL
NFAT	NULL
proteins	NULL
(	NULL
NFATp	NULL
and	NULL
NFATc	NULL
)	NULL
nor	NULL
EGR-1	NULL
display	NULL
a	NULL
common	NULL
motif	NULL
indicative	NULL
for	NULL
this	NULL
kind	NULL
of	NULL
interaction	NULL
.	NULL

Additional	NULL
experiments	NULL
aimed	NULL
at	NULL
describing	NULL
the	NULL
interaction	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
will	NULL
contribute	NULL
to	NULL
an	NULL
understanding	NULL
of	NULL
their	NULL
synergism	NULL
of	NULL
action	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
22506	NULL
TaBLE	NULL
I	NULL
Luciferase	NULL
activity	NULL
of	NULL
IL-2	NULL
promoter	NULL
constructs	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
The	NULL
numbers	NULL
represent	NULL
light	NULL
units	NULL
obtained	NULL
upon	NULL
transfection	NULL
of	NULL
the	NULL
indicated	NULL
constructs	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
unstimulated	NULL
cells	NULL
(	NULL
uninduced	NULL
)	NULL
and	NULL
from	NULL
cells	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
PHA	NULL
and	NULL
PMA	NULL
(	NULL
induced	NULL
)	NULL
.	NULL

The	NULL
mean	NULL
values	NULL
of	NULL
at	NULL
least	NULL
three	NULL
(	NULL
uninduced	NULL
)	NULL
or	NULL
five	NULL
(	NULL
induced	NULL
)	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

All	NULL
numbers	NULL
are	NULL
corrected	NULL
for	NULL
background	NULL
luminescence	NULL
(	NULL
about	NULL
300	NULL
light	NULL
units	NULL
)	NULL
,	NULL
and	NULL
standard	NULL
deviations	NULL
are	NULL
shown	NULL
in	NULL
parentheses	NULL
.	NULL

Light	NULL
units	NULL
Construct	NULL
-Fold	NULL
induction	NULL
Uninduced	NULL
Induced	NULL
pClLuel	NULL
421	NULL
(	NULL
166	NULL
)	NULL
40	NULL
630	NULL
(	NULL
5821	NULL
)	NULL
96.5	NULL
pClLuc2	NULL
455	NULL
(	NULL
165	NULL
)	NULL
28	NULL
785	NULL
(	NULL
8802	NULL
)	NULL
63.3	NULL
pClLues	NULL
479	NULL
(	NULL
293	NULL
)	NULL
10	NULL
502	NULL
(	NULL
2000	NULL
)	NULL
18.2	NULL
pClLued	NULL
333	NULL
(	NULL
81	NULL
)	NULL
3	NULL
402	NULL
(	NULL
576	NULL
)	NULL
10.2	NULL
pMILucl	NULL
416	NULL
(	NULL
117	NULL
)	NULL
7	NULL
309	NULL
(	NULL
1427	NULL
)	NULL
17.6	NULL
pMILuc2	NULL
190	NULL
(	NULL
86	NULL
)	NULL
851	NULL
(	NULL
359	NULL
)	NULL
4.5	NULL
pMILuc3	NULL
438	NULL
(	NULL
139	NULL
)	NULL
1	NULL
417	NULL
(	NULL
540	NULL
)	NULL
3.2	NULL
pMILued	NULL
165	NULL
(	NULL
47	NULL
)	NULL
341	NULL
(	NULL
123	NULL
)	NULL
2.1	NULL
300	NULL
250	NULL
A	NULL
Mouse	NULL
5	NULL
ct	NULL
crf	NULL
:	NULL
an	NULL
3	NULL
Accamacecer	NULL
3	NULL
Human	NULL
55	NULL
or	NULL
arege	NULL
-	NULL
TEXT	NULL
acaGragecer	NULL
3	NULL
'	NULL
s	NULL
-250	NULL
Binding	NULL
site	NULL
ZIP	NULL
NFAT	NULL
AP-1	NULL
B	NULL
C-290	NULL
C-298	NULL
Mouse	NULL
5Â°	NULL
G	NULL
G	NULL
G	NULL
G	NULL
T	NULL
G	NULL
G	NULL
A	NULL
G0	NULL
3	NULL
``	NULL
Human	NULL
5Â°	NULL
G	NULL
G	NULL
6	NULL
6	NULL
T	NULL
6	NULL
G	NULL
6	NULL
Â¢	NULL
3	NULL
``	NULL
C-289	NULL
C-297	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Conservation	NULL
of	NULL
ZIP	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
IL-2	NULL
promoter	NULL
region	NULL
.	NULL

A	NULL
,	NULL
the	NULL
nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
region	NULL
,	NULL
position	NULL
-303	NULL
to	NULL
-250	NULL
bp	NULL
upstream	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
is	NULL
aligned	NULL
with	NULL
the	NULL
mouse	NULL
IL-2	NULL
promoter	NULL
region	NULL
.	NULL

The	NULL
ZIP	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
AP-1	NULL
sites	NULL
are	NULL
boxed	NULL
,	NULL
the	NULL
region	NULL
inserted	NULL
in	NULL
the	NULL
mouse	NULL
promoter	NULL
is	NULL
indicated	NULL
by	NULL
colons	NULL
.	NULL

B	NULL
,	NULL
alignment	NULL
of	NULL
the	NULL
complementary	NULL
G-rich	NULL
zinc	NULL
finger	NULL
binding	NULL
elements	NULL
of	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
IL-2	NULL
gene	NULL
promoters	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
zinc	NULL
finger	NULL
proteins	NULL
Sp1	NULL
and	NULL
EGR-1	NULL
are	NULL
part	NULL
of	NULL
this	NULL
transcriptional	NULL
machinery	NULL
which	NULL
regulate	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
growth	NULL
factor	NULL
IL-2	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
R.	NULL
Tjian	NULL
for	NULL
providing	NULL
plasmid	NULL
pPacÂ§p1	NULL
,	NULL
Uli	NULL
Siebenlist	NULL
for	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
region	NULL
,	NULL
and	NULL
Joachim	NULL
Clos	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
355-361	NULL
2	NULL
.	NULL

Zipfel	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
Irving	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
1041-1048	NULL
3	NULL
.	NULL

Suggs	NULL
,	NULL
S.	NULL
V.	NULL
,	NULL
Katzowitz	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Tsai-Morris	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
4283-4288	NULL
4	NULL
.	NULL

Joseph	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Le	NULL
Beau	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Jamieson	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Jr.	NULL
,	NULL
Acharya	NULL
,	NULL
S.	NULL
,	NULL
Shows	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
7164-7168	NULL
5	NULL
.	NULL

Patwardhan	NULL
,	NULL
S.	NULL
,	NULL
Gashler	NULL
,	NULL
A.	NULL
,	NULL
Siegel	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Chang	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Joseph	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Shows	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
Le	NULL
Beau	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
917-928	NULL
6	NULL
.	NULL

Mages	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
Stamminger	NULL
,	NULL
T.	NULL
,	NULL
Rilke	NULL
,	NULL
O.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kroczek	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Intern	NULL
.	NULL

Immunol	NULL
.	NULL

5	NULL
,	NULL
63-70	NULL
Zinc	NULL
Finger	NULL
Binding	NULL
Element	NULL
in	NULL
7	NULL
8	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43.	NULL
the	NULL
Human	NULL
IL-2	NULL
Promoter	NULL
.	NULL

Miller	NULL
,	NULL
H.-J	NULL
.	NULL

,	NULL
Skerka	NULL
,	NULL
C.	NULL
,	NULL
Bialonski	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Zipfel	NULL
,	NULL
P.	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Naf	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
10079-10083	NULL
.	NULL

Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
Kartha	NULL
,	NULL
S.	NULL
,	NULL
Toback	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
Taub	NULL
,	NULL
R.	NULL
,	NULL
Hoover	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Tsai-Morris	NULL
,	NULL
C.-H.	NULL
(	NULL
1987	NULL
)	NULL
Oncogene	NULL
Res	NULL
.	NULL

1	NULL
,	NULL
3483-355	NULL
.	NULL

Milbrandt	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Science	NULL
288	NULL
,	NULL
797-799	NULL
.	NULL

Christy	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Lau	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
7857-7861	NULL
.	NULL

Lemaire	NULL
,	NULL
P.	NULL
,	NULL
Revelant	NULL
,	NULL
O.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Charnay	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
4691-4695	NULL
.	NULL

Chavrier	NULL
,	NULL
P.	NULL
,	NULL
Zerial	NULL
,	NULL
M.	NULL
,	NULL
Lemaire	NULL
,	NULL
P.	NULL
,	NULL
Almandral	NULL
,	NULL
J.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Charnay	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
29-35	NULL
Crosby	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Puetz	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Sirmburger	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Fahmer	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Milbrandt	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
3835-3841	NULL
Christy	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
8737-8741	NULL
Cao	NULL
,	NULL
X.	NULL
,	NULL
Mahendran	NULL
,	NULL
R.	NULL
,	NULL
Guy	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Tan	NULL
,	NULL
Y.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
16949-16957	NULL
Pavletich	NULL
,	NULL
N.	NULL
P.	NULL
,	NULL
and	NULL
Pabo	NULL
,	NULL
C.	NULL
O	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
252	NULL
,	NULL
809-817	NULL
Lemaire	NULL
,	NULL
P.	NULL
,	NULL
Vesque	NULL
,	NULL
C.	NULL
,	NULL
Schmitt	NULL
,	NULL
J.	NULL
,	NULL
Stunnenberg	NULL
,	NULL
H.	NULL
,	NULL
Frank	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Carnay	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
3456-3467	NULL
Chavrier	NULL
,	NULL
P.	NULL
,	NULL
Vesque	NULL
,	NULL
C.	NULL
,	NULL
Galliot	NULL
,	NULL
B.	NULL
,	NULL
Vigneron	NULL
,	NULL
M.	NULL
,	NULL
DollÃ©	NULL
,	NULL
P.	NULL
,	NULL
Dubole	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Charnay	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
1209-1218	NULL
Krimer	NULL
,	NULL
B.	NULL
,	NULL
Meichle	NULL
,	NULL
A.	NULL
,	NULL
Hensel	NULL
,	NULL
G.	NULL
,	NULL
Charnay	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
KrÃ©nke	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1219	NULL
,	NULL
418-421	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Shaw	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Bush	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Replogle	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Belagaje	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1715-1724	NULL
Kamps	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Corcoran	NULL
,	NULL
L.	NULL
,	NULL
Lebowitz	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
5464-5472	NULL
Granelli-Piperno	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Nolan	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
2734-2739	NULL
Garrity	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
D.	NULL
,	NULL
von	NULL
Rothenberg	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Wold	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
2159-2169	NULL
Serfling	NULL
,	NULL
E.	NULL
,	NULL
Avots	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Neumann	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
in	NULL
press	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Chen	NULL
,	NULL
L.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
369	NULL
,	NULL
497-502	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
274-281	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
795-798	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Valge-Archer	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
356	NULL
,	NULL
801-804	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
Kerpolla	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Badalian	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Burgeon	NULL
,	NULL
E.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
750-754	NULL
O'Reilly	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Miller	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
Luckow	NULL
,	NULL
V.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Baculovirus	NULL
Expression	NULL
Vectors	NULL
,	NULL
Freeman	NULL
and	NULL
Company	NULL
,	NULL
New	NULL
York	NULL
Ragona	NULL
,	NULL
G.	NULL
,	NULL
Edvards	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Mercola	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Adamson	NULL
,	NULL
E.	NULL
D.	NULL
,	NULL
and	NULL
Calogero	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
DNA	NULL
Cell	NULL
Biol	NULL
.	NULL

10	NULL
,	NULL
61-66	NULL
Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5299	NULL
Wright	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Gunther	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Mitsuya	NULL
,	NULL
H.	NULL
,	NULL
Irving	NULL
S.	NULL
G.	NULL
,	NULL
Kelly	NULL
,	NULL
K	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
588-591	NULL
Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Higgins	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Lacy	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
1617-1620	NULL
Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
85	NULL
,	NULL
79-87	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
,	NULL
Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
292	NULL
,	NULL
755-759	NULL
Nardelli	NULL
,	NULL
J.	NULL
,	NULL
Gibson	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Vesque	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Charnay	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
849	NULL
,	NULL
175-178	NULL
Yu	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
Motamed	NULL
,	NULL
K.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
,	NULL
Baily	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Shen	NULL
,	NULL
C.	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
8907-8915	NULL
Ackermann	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Minden	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Williams	NULL
,	NULL
G.	NULL
T.	NULL
,	NULL
Bobonis	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Yeung	NULL
,	NULL
C.	NULL
Y	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
7528-7527	NULL
Shingu	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Bornstein	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
32551-32557	NULL
Gashler	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Swaninathan	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
4556-4571	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Guidos	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
15788-15795	NULL
Chen	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
von	NULL
Rothenberg	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
228-237	NULL
.	NULL

Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Corthesy	NULL
,	NULL
B.	NULL
,	NULL
Bram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
352	NULL
,	NULL
803-807	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
A	NULL
Regulatory	NULL
Element	NULL
in	NULL
the	NULL
Human	NULL
Interleukin	NULL
2	NULL
Gene	NULL
Promoter	NULL
Is	NULL
a	NULL
Binding	NULL
Site	NULL
for	NULL
the	NULL
Zinc	NULL
Finger	NULL
Proteins	NULL
Spl	NULL
and	NULL
EGR-1	NULL
Christine	NULL
Skerka	NULL
,	NULL
Eva	NULL
L.	NULL
Decker	NULL
and	NULL
Peter	NULL
F.	NULL
Zipfel	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1995	NULL
,	NULL
270:22500-22506.	NULL
doi	NULL
:	NULL
10.1074/jb0.270.38.22500	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/270/38/22500	NULL
Alerts	NULL
:	NULL
Â«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
Â«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
42	NULL
references	NULL
,	NULL
26	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10Â°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

